Chen Jing, Ho Chin-Yen, Tu Yu-Kang, Lin Yi-Chih, Hsia Yun, Lin Ying-Chun, Shantakumar Sumitra
GSK, Singapore.
Health Data Research Center, National Taiwan University, Taipei, Taiwan.
Hum Vaccin Immunother. 2025 Dec;21(1):2496048. doi: 10.1080/21645515.2025.2496048. Epub 2025 Apr 29.
Asia-Pacific (APAC) faces an increasing burden of herpes zoster (HZ) over time. The risk of HZ and its complications are increased in immunocompromised (IC) patients and those with autoimmune diseases (AID). Our study aimed to synthesize evidence on the epidemiological burden of HZ and its complications among the general adult population and patients with IC/AID conditions in APAC. Following a systematic literature review, we performed meta-analyses for outcomes where ≥3 studies met the inclusion criteria. Of the 271 articles identified, 75 were included for meta-analysis. We found a high burden of HZ and its complications (i.e., postherpetic neuralgia, HZ ophthalmicus), particularly among individuals with IC/AID conditions in APAC. Patients with IC/AID conditions had significantly increased HZ risk and a higher proportion of HZ recurrence than the general adult population. These findings may inform clinical practice and public health decisions regarding HZ prevention, including HZ vaccination strategies, among the IC/AID population in APAC.
随着时间的推移,亚太地区(APAC)带状疱疹(HZ)的负担日益加重。免疫功能低下(IC)患者和自身免疫性疾病(AID)患者发生HZ及其并发症的风险会增加。我们的研究旨在综合亚太地区普通成年人群以及IC/AID患者中HZ及其并发症的流行病学负担的证据。在进行系统的文献综述之后,我们对≥3项研究符合纳入标准的结局进行了荟萃分析。在确定的271篇文章中,75篇被纳入荟萃分析。我们发现HZ及其并发症(即带状疱疹后神经痛、眼部带状疱疹)的负担很重,尤其是在亚太地区的IC/AID患者中。与普通成年人群相比,IC/AID患者发生HZ的风险显著增加,且HZ复发的比例更高。这些发现可能为亚太地区IC/AID人群中有关HZ预防(包括HZ疫苗接种策略)的临床实践和公共卫生决策提供参考。